Lauren King
Gerontology · Mobile, ALNPI 1467807487
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $526 and has fallen 68.0% since, to $168 in 2025.
Across 74 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$236
- Johnson & Johnson$169
- Incyte Corporation$169
- Regeneron Healthcare Solutions, Inc.$161
- AstraZeneca$148
- Eisai Inc.$133
- plus $507 from 17 others
What the payments were for
- Food & beverage$1,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $236 |
| Johnson & Johnson(2 entities) | 10 | $169 |
| Incyte Corporation | 7 | $169 |
| Regeneron Healthcare Solutions, Inc. | 7 | $161 |
| AstraZeneca | 3 | $148 |
| Eisai Inc. | 7 | $133 |
| Lilly USA, LLC | 5 | $80 |
| Boehringer Ingelheim | 3 | $59 |
| ADC Therapeutics America, Inc. | 2 | $39 |
| Baxter Healthcare | 2 | $39 |
| Misonix Inc | 2 | $36 |
| Immunogen, Inc. | 2 | $34 |
| Stemline Therapeutics Inc. | 2 | $33 |
| AbbVie | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $22 |
| Seagen Inc. | 1 | $20 |
| Acrotech Biopharma Inc. | 1 | $17 |
| EMD Serono, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Myovant Sciences Inc. | 1 | $13 |
| Morphosys, US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$118
How this compares
$1,523 in reported general payments places this provider in the 70th percentile of 143 gerontology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,836 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,263 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $255 |
| Prednisone | 94 | $215 |
| Cefdinir | 15 | $171 |
| Doxycycline Hyclate | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Mobile
- Michelle SanfordMobile$11K
- Stephanie FoutsMobile$7K
- Alicia LandMobile$5K
- Tasha JonesMobile$4K
- Krishna JefcoatMobile$2K
- Kathleen FergusonMobile$2K
- Amy OdomMobile$1K
- Ryan ShannonMontgomery$66K
- Claire BruceHuntsville$12K
- Virginia McNeillNorthport$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.